Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

10.44
Delayed Data
As of 4:00pm ET
 +0.35 / +3.47%
Today’s Change
8.27
Today|||52-Week Range
25.25
-34.83%
Year-to-Date

Today’s Trading

Previous close10.09
Today’s open10.32
Day’s range9.93 - 10.68
Volume370,165
Average volume (3 months)374,784
Market cap$577.4M
Dividend yield--
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.15+2.81%
EGRXEagle Pharmaceutical...+1.50+4.01%
MNKDMannKind Corp0.000.00%
INSMInsmed Inc+0.16+1.65%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs